The US Alzheimers disease patients market is growing steadily due to the increasing aging population, rising prevalence of dementia, and strong investments in neurological research. Advanced healthcare infrastructure, ongoing clinical trials, and the presence of leading pharmaceutical companies are accelerating the development and adoption of innovative diagnostic and therapeutic solutions....